4.6 Article

Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease

Related references

Note: Only part of the references are listed.
Article Pediatrics

B cell-activating factor (BAFF) in children with inflammatory bowel disease

Ioana Fodor et al.

Summary: This study evaluated the value of BAFF as a potential biomarker in pediatric inflammatory bowel disease, finding that fecal BAFF is a promising marker for monitoring children with IBD, with higher levels being correlated with high levels of fecal calprotectin. This could potentially serve as a non-invasive marker for monitoring IBD activity in children with clinically mild or inactive disease.

PEDIATRIC RESEARCH (2021)

Article Gastroenterology & Hepatology

ACG Clinical Guideline: Management of Irritable Bowel Syndrome

Brian E. Lacy et al.

Summary: Irritable bowel syndrome (IBS) is a chronic disorder that significantly impacts patients' quality of life. The American College of Gastroenterology has developed a clinical guideline using GRADE methodology for the management of IBS, recommending a positive diagnostic approach, specific tests, treatments, and gut-directed psychotherapy to improve symptoms for patients with IBS.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment

Nikolaos-Panagiotis Andreou et al.

Summary: The study found that BAFF levels were elevated in CD patients, and responders to infliximab treatment had significantly higher baseline BAFF levels. Additionally, the SNP rs1041569 was associated with CD susceptibility.

DIGESTIVE AND LIVER DISEASE (2021)

Article Gastroenterology & Hepatology

Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues

Mirae Lee et al.

Summary: Inflammatory bowel diseases (IBD) result from the interaction of environmental, microbial, immunological, and genetic factors, with alterations in the gut microbiota playing a role in their development and progression. The use of microbiome-based therapies can potentially prevent, manage, and cure IBD, bridging the gap between basic sciences and clinical application through research findings.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018

Valdimar B. Kristjansson et al.

Summary: The study in Iceland found that patients treated with rituximab have a sixfold increased risk of developing inflammatory bowel disease (IBD) compared to the general population, regardless of dosage or treatment duration. Prior diagnosis of an autoimmune illness did not increase the risk of IBD in rituximab treated patients.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)

Review Immunology

Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies

Junjun Zhao et al.

Summary: Autoimmune diseases are complex and closely related to CD4+ T helper cells. Th17 cells play a key role in the pathogenesis of autoimmune bowel disease.

JOURNAL OF IMMUNOLOGY RESEARCH (2021)

Review Microbiology

Immunoglobulin A, an Active Liaison for Host-Microbiota Homeostasis

Ahmed A. Abokor et al.

Summary: This review highlights the important role of Immunoglobulin A (IgA) in the gastrointestinal tract mucosal surfaces and its interdependence with the microbiota. Studies show that the source and structural form of IgA are crucial for microbiota reactivity, which helps maintain a symbiotic relationship between the host and bacteria.

MICROORGANISMS (2021)

Review Medicine, General & Internal

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis

Mariusz A. Bromke et al.

Summary: The use of fecal calprotectin in monitoring mucosal healing in colonic Crohn's disease and ulcerative colitis shows good sensitivity and specificity, as well as a high diagnostic odds ratio. This non-invasive test may present an attractive option for monitoring mucosal healing in patients with inflammatory bowel disease.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Gastroenterology & Hepatology

Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence

Marko Kumric et al.

Summary: The COVID-19 outbreak since December 2019 in China has become the biggest medical issue of modern medicine, with high mortality among patients with multiple co-morbidities and overcapacity of intensive care units amplifying the impact. In the gastroenterology-related community, concern has been raised regarding patients with inflammatory bowel disease (IBD) and their susceptibility to opportunistic infections due to immunosuppressive-based therapies. The outcomes of infected patients seem to be largely dependent on the therapeutic modality they receive, with some worsening the clinical course of the infection and others mitigating its effects.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Article Medicine, General & Internal

Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease

Piero Marin Zivkovic et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Multidisciplinary Sciences

Serum adropin levels are reduced in patients with inflammatory bowel diseases

Darko Brnic et al.

SCIENTIFIC REPORTS (2020)

Review Immunology

The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease

Jun-bin Yan et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2020)

Article Gastroenterology & Hepatology

Recurrent Abdominal Pain in Children: Is Colonoscopy Indicated?

Harveen K. Singh et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)

Review Medical Laboratory Technology

Clinical value of fecal calprotectin

Amanda Ricciuto et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2019)

Article Immunology

Diagnostic value of fecal B cell activating factor in patients with abdominal discomfort

C. Xie et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)

Review Pharmacology & Pharmacy

Belimumab: A Review in Systemic Lupus Erythematosus

Hannah A. Blair et al.

DRUGS (2018)

Review Gastroenterology & Hepatology

From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting

Maria Gloria Mumolo et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse

Vipul Aggarwal et al.

GASTROINTESTINAL ENDOSCOPY (2017)

Article Gastroenterology & Hepatology

Intestinal IgA as a modulator of the gut microbiota

Shinsaku Okai et al.

GUT MICROBES (2017)

Editorial Material Gastroenterology & Hepatology

B Cell-Activating Factor (BAFF) in Inflammatory Bowel Disease: BAFFling No Longer?

Ilja Striz

DIGESTIVE DISEASES AND SCIENCES (2016)

Review Gastroenterology & Hepatology

B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases

Mathieu Uzzan et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Article Gastroenterology & Hepatology

B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease

Peipei Zhang et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Article Biotechnology & Applied Microbiology

Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser

Morton A. Scheinberg et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2016)

Article Gastroenterology & Hepatology

Ulcerative Colitis Is Characterized by a Decrease in Regulatory B Cells

Xinrui Wang et al.

JOURNAL OF CROHNS & COLITIS (2016)

Review Medicine, Research & Experimental

Signaling via the NFκB system

Simon Mitchell et al.

WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2016)

Review Immunology

Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides

Nicolas Dumoitier et al.

AUTOIMMUNITY REVIEWS (2015)

Review Medicine, Research & Experimental

Cytokine networking of innate immunity cells: a potential target of therapy

Ilja Striz et al.

CLINICAL SCIENCE (2014)

Article Immunology

New treatments for inflammatory rheumatic disease

Carlo Selmi et al.

IMMUNOLOGIC RESEARCH (2014)

Review Gastroenterology & Hepatology

The Role of Macrophages and Dendritic Cells in the Initiation of Inflammation in IBD

Erin C. Steinbach et al.

INFLAMMATORY BOWEL DISEASES (2014)

Article Dermatology

Rituximab Induced Psoriasis in an Infant

Loretta Fiorillo et al.

PEDIATRIC DERMATOLOGY (2014)

Article Gastroenterology & Hepatology

Inflammatory bowel disease: Pathogenesis

Yi-Zhen Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Cell Biology

BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus

Fabien B. Vincent et al.

IMMUNOLOGY AND CELL BIOLOGY (2012)

Article Gastroenterology & Hepatology

Effect of Bowel Cleansing for Colonoscopy on Fecal Calprotectin Levels in Pediatric Patients

Kaija-Leena Kolho et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)

Article Medicine, General & Internal

Ulcerative colitis

Ingrid Ordas et al.

LANCET (2012)

Article Medicine, General & Internal

Crohn's disease

Daniel C. Baumgart et al.

LANCET (2012)

Article Gastroenterology & Hepatology

Recent Insights Into the Genetics of Inflammatory Bowel Disease

Judy H. Cho et al.

GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Systemic Toll-Like Receptor Ligands Modify B-cell Responses in Human Inflammatory Bowel Disease

Marie McDonnell et al.

INFLAMMATORY BOWEL DISEASES (2011)

Article Rheumatology

Refractory Urticarial Vasculitis as a Complication of Ulcerative Colitis Successfully Treated With Rituximab

Arun Swaminath et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2011)

Review Immunology

Mucosal Macrophages in Intestinal Homeostasis and Inflammation

Allan McI Mowat

JOURNAL OF INNATE IMMUNITY (2011)

Review Immunology

BAFF and selection of autoreactive B cells

Zheng Liu et al.

TRENDS IN IMMUNOLOGY (2011)

Article Gastroenterology & Hepatology

Intestinal B cell-activating factor: an indicator of non-IgE-mediated hypersensitivity reactions to food?

G. Arslan Lied et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)

Review Gastroenterology & Hepatology

Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy

Anja Schirbel et al.

JOURNAL OF DIGESTIVE DISEASES (2010)

Article Pediatrics

Severe Ulcerative Colitis After Rituximab Therapy

Daniela S. Ardelean et al.

PEDIATRICS (2010)

Article Oncology

A critical role for the NFkB pathway in multiple myeloma

Yulia N. Demchenko et al.

ONCOTARGET (2010)

Article Gastroenterology & Hepatology

Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse

Javier P. Gisbert et al.

INFLAMMATORY BOWEL DISEASES (2009)

Article Gastroenterology & Hepatology

Isoflavones regulate innate immunity and inhibit experimental colitis

Masakazu Morimoto et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

Alterations of peripheral blood CD5+B cells in inflammatory bowel disease

Yoshiyuki Mishima et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)

Review Immunology

Cracking the BAFF code

Fabienne Mackay et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Article Gastroenterology & Hepatology

Complications of pediatric colonoscopy: A five-year multicenter experience

Kalpesh Thakkar et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)

Article Gastroenterology & Hepatology

Exacerbation of ulcerative colitis after rituximab salvage therapy

Martin Goetz et al.

INFLAMMATORY BOWEL DISEASES (2007)

Article Immunology

In vitro and in vivo activation induces BAFF and APRIL expression in B cells

Van Trung Chu et al.

JOURNAL OF IMMUNOLOGY (2007)

Review Biochemistry & Molecular Biology

NF-κB and the immune response

M. S. Hayden et al.

ONCOGENE (2006)

Article Hematology

A role for BLyS in the activation of innate immune cells

Sock Kyung Chang et al.

BLOOD (2006)

Review Immunology

The role of the BAFF/APRIL system on T cell function

Fabienne Mackay et al.

SEMINARS IN IMMUNOLOGY (2006)

Review Immunology

The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjogren's syndrome

P Szodoray et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)

Article Medicine, Research & Experimental

BLyS and APRIL in rheumatoid arthritis

TM Seyler et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Article Immunology

BAFF production by antigen-presenting cells provides T cell co-stimulation

B Huard et al.

INTERNATIONAL IMMUNOLOGY (2004)

Article Medicine, Research & Experimental

Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease

TS Olson et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Review Biochemistry & Molecular Biology

The uncertain glory of APRIL

JP Medema et al.

CELL DEATH AND DIFFERENTIATION (2003)

Article Rheumatology

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome

X Mariette et al.

ANNALS OF THE RHEUMATIC DISEASES (2003)

Review Biochemistry & Molecular Biology

Mechanism of BLyS action in B cell immunity

RKG Do et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2002)

Article Multidisciplinary Sciences

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

JS Thompson et al.

SCIENCE (2001)

Article Medicine, General & Internal

Cost-effectiveness of endoscopy in irritable bowel syndrome

S Suleiman et al.

ARCHIVES OF INTERNAL MEDICINE (2001)